Carboprost trometamol is a synthetic analogue of the naturally occurring prostaglandin F2α, functioning as a potent uterotonic agent used to induce strong uterine contractions. This pharmaceutical is primarily… Read more












Carboprost trometamol is a synthetic analogue of the naturally occurring prostaglandin F2α, functioning as a potent uterotonic agent used to induce strong uterine contractions. This pharmaceutical is primarily indicated for the management of postpartum hemorrhage due to uterine atony and may also be utilized to induce abortion during the second trimester of pregnancy. To ensure drug safety and manufacturing consistency, laboratories rely on a comprehensive range of reference standards, including the active ingredient, related degradation products, impurities, and stable isotope labelled compounds. These high-quality standards are essential for accurate impurity profiling and rigorous analytical method validation, such as HPLC or LC-MS techniques. By employing these precise materials in quality control testing, researchers and manufacturers can effectively identify, quantify, and monitor impurities, ensuring that the final drug product meets stringent regulatory specifications and maintains therapeutic efficacy.